Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Carlsmed Inc (CARL)

Carlsmed Inc (CARL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 339,593
  • Shares Outstanding, K 26,593
  • Annual Sales, $ 27,170 K
  • Annual Income, $ -24,260 K
  • EBIT $ -23 M
  • EBITDA $ -23 M
  • 60-Month Beta N/A
  • Price/Sales 7.61
  • Price/Cash Flow N/A
  • Price/Book 3.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.43
  • Number of Estimates 3
  • High Estimate -0.32
  • Low Estimate -0.57
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.65 +19.91%
on 02/12/26
13.75 -7.13%
on 01/27/26
+0.09 (+0.71%)
since 01/20/26
3-Month
10.65 +19.91%
on 02/12/26
17.19 -25.71%
on 12/03/25
+0.95 (+8.04%)
since 11/20/25

Most Recent Stories

More News
Carlsmed Announces first corra™ personalized Cervical Plating Procedure

CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the first personalized cervical plating procedure using the corra™...

CARL : 12.77 (+2.08%)
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report...

CARL : 12.77 (+2.08%)
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful completion of the first posterior lumbar spine...

CARL : 12.77 (+2.08%)
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024 Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024 CARLSBAD, Calif., Jan. 12, 2026...

CARL : 12.77 (+2.08%)
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal

CARLSBAD, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the publication of a new retrospective cohort study in  Global...

CARL : 12.77 (+2.08%)
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference

CARLSBAD, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed will be presenting...

CARL : 12.77 (+2.08%)
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting...

CARL : 12.77 (+2.08%)
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance

Third quarter revenue of $13.1 million, representing 98% growth YoY   Raising full year 2025 revenue guidance to $49 million - $50 million CARLSBAD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Carlsmed,...

CARL : 12.77 (+2.08%)
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025

CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report...

CARL : 12.77 (+2.08%)

Business Summary

Carlsmed Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. Carlsmed Inc. is based in CARLSBAD, Calif.

See More

Key Turning Points

3rd Resistance Point 13.55
2nd Resistance Point 13.18
1st Resistance Point 12.97
Last Price 12.77
1st Support Level 12.39
2nd Support Level 12.02
3rd Support Level 11.81

See More

52-Week High 17.19
Fibonacci 61.8% 14.69
Fibonacci 50% 13.92
Fibonacci 38.2% 13.15
Last Price 12.77
52-Week Low 10.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar